No Data
No Data
Yongtai Biotechnology-B (06978.HK) held a board of directors meeting on August 23 to consider and approve the mid-term performance.
On August 13th, GeLingHui announced that Yongtai Biology-B (06978.HK) plans to hold a board of directors meeting on August 23, 2024 (Friday) to consider and approve the mid-term performance of the company and its subsidiaries for the six months ending June 30, 2024, including its publication.
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Immunotech Biopharm CFO Steps Down
Yongtai Biological announced that Chen Ran has been appointed as Joint Company Secretary.
Yongtai Biology-B (06978) announced that Yang Ning has resigned as the Chief Financial Officer and Company Secretary due to his other business responsibilities and will no longer serve as the authorized representative of the company in accordance with Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange, effective from July 26, 2024. Chen Ran and Leung Yui Ping have been appointed as the Joint Company Secretaries of the company; and Chen Ran has been appointed as the authorized representative, effective from July 26, 2024.
Yongtai Biotechnology-B (06978.HK): Yang Ning resigns as CFO.
On July 26th, Gelunhui announced that Mr. Yang Ning resigned as the company's CFO and company secretary due to his other business responsibilities, and in accordance with Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange, he will no longer serve as the authorized representative of the company, which will take effect on July 26, 2024. The board of directors is pleased to announce that (i) Mr. Chen Ran and Ms. Liang Ruibing have been appointed as joint company secretaries of the company; and (ii) Mr. Chen has been appointed as an authorized representative, which will take effect on July 26, 2024.
Express News | Immunotech Biopharm Ltd - Yang Ning Resigned as CFO
No Data